Found: 139
Select item for more details and to access through your institution.
Adherence with early infant feeding and complementary feeding guidelines in the Cork BASELINE Birth Cohort Study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis: A Post Hoc Analysis of 6 Randomized Clinical Trials.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 3, p. 255, doi. 10.1001/jamadermatol.2022.6192
- By:
- Publication type:
- Article
Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 1, p. 1, doi. 10.1007/s40257-021-00639-y
- By:
- Publication type:
- Article
Long-lasting behavioural consequences of neonatal iron deficiency in high-risk children.
- Published in:
- 2020
- By:
- Publication type:
- Abstract
Long-lasting behavioural consequences of neonatal iron deficiency in high-risk children.
- Published in:
- 2020
- By:
- Publication type:
- Abstract
Old King coal - molecular mechanisms underlying an ancient treatment for atopic eczema.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Old King Coal -- molecular mechanisms underlying an ancient treatment for atopic eczema.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 2, p. 934, doi. 10.1172/JCI67438
- By:
- Publication type:
- Article
Antenatal Vitamin D Status Is Not Associated with Standard Neurodevelopmental Assessments at Age 5 Years in a Well-Characterized Prospective Maternal-Infant Cohort.
- Published in:
- Journal of Clinical Chiropractic Pediatrics, 2021, v. 20, n. 1, p. 1580, doi. 10.1093/jn/nxy150
- By:
- Publication type:
- Article
A case of congenital solitary Langerhans cell histiocytoma.
- Published in:
- Australasian Journal of Dermatology, 2011, v. 52, n. 2, p. e1, doi. 10.1111/j.1440-0960.2010.00625.x
- By:
- Publication type:
- Article
Variation in iodine food composition data has a major impact on estimates of iodine intake in young children.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Second International Conference on a classification of ectodermal dysplasias: Development of a multiaxis model.
- Published in:
- American Journal of Medical Genetics. Part A, 2014, v. 164A, n. 10, p. 2482, doi. 10.1002/ajmg.a.36507
- By:
- Publication type:
- Article
Methylenetetrahydrofolate reductase (MTHFR) deficiency presenting as a rash.
- Published in:
- American Journal of Medical Genetics. Part A, 2012, v. 158A, n. 9, p. 2254, doi. 10.1002/ajmg.a.35479
- By:
- Publication type:
- Article
Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 1, p. 38, doi. 10.1111/bjh.13557
- By:
- Publication type:
- Article
Kasabach-Merritt syndrome, kaposiform haemangioendothelioma and platelet blockade.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 1, p. 11, doi. 10.1111/bjh.13558
- By:
- Publication type:
- Article
Haploinsufficiency for AAGAB causes clinically heterogeneous forms of punctate palmoplantar keratoderma.
- Published in:
- Nature Genetics, 2012, v. 44, n. 11, p. 1272, doi. 10.1038/ng.2444
- By:
- Publication type:
- Article
A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming.
- Published in:
- Nature Genetics, 2009, v. 41, n. 5, p. 602, doi. 10.1038/ng.358
- By:
- Publication type:
- Article
Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris.
- Published in:
- Nature Genetics, 2006, v. 38, n. 3, p. 337, doi. 10.1038/ng1743
- By:
- Publication type:
- Article
Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis.
- Published in:
- Nature Genetics, 2006, v. 38, n. 4, p. 441, doi. 10.1038/ng1767
- By:
- Publication type:
- Article
Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome.
- Published in:
- Nature Genetics, 2000, v. 25, n. 2, p. 141, doi. 10.1038/75977
- By:
- Publication type:
- Article
PHACE syndrome: MRI of intracerebral vascular anomalies and clinical findings in a series of 12 patients.
- Published in:
- Pediatric Radiology, 2011, v. 41, n. 9, p. 1129, doi. 10.1007/s00247-011-2142-z
- By:
- Publication type:
- Article
A real‐world retrospective observational study exploring resource use for secondary care management of moderate‐to‐severe atopic dermatitis in children and adolescents at a single site in Ireland.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 465, doi. 10.1002/jvc2.142
- By:
- Publication type:
- Article
More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2621, doi. 10.1007/s13555-024-01242-9
- By:
- Publication type:
- Article
Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 7, p. 1517, doi. 10.1007/s13555-023-00942-y
- By:
- Publication type:
- Article
SVEP1 plays a crucial role in epidermal differentiation.
- Published in:
- Experimental Dermatology, 2017, v. 26, n. 5, p. 423, doi. 10.1111/exd.13256
- By:
- Publication type:
- Article
Development of Allele-Specific Therapeutic siRNA in Meesmann Epithelial Corneal Dystrophy.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0028582
- By:
- Publication type:
- Article
Carrier Status for the Common R501X and 2282del4 Filaggrin Mutations Is Not Associated with Hearing Phenotypes in 5377 Children from the ALSPAC Cohort.
- Published in:
- PLoS ONE, 2009, v. 4, n. 6, p. 1, doi. 10.1371/journal.pone.0005784
- By:
- Publication type:
- Article
696 - Sustained improvements over 140 weeks in signs, symptoms, and quality of life with upadacitinib in adolescents and adults with moderate-to-severe atopic dermatitis: integrated results from the phase 3 Measure Up 1 and Measure Up 2 studies.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.070
- By:
- Publication type:
- Article
693 - Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS).
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.067
- By:
- Publication type:
- Article
692 - Dupilumab reduces atopic dermatitis lesion severity and extent in children <12 years of age with moderate-to-severe AD: interim results from the PEDISTAD real-world registry.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.066
- By:
- Publication type:
- Article
676 - Dupilumab increases levels of bone growth biomarker irrespective of prior use of systemic corticosteroids in children with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.050
- By:
- Publication type:
- Article
629 - A novel efficacy index for long-term therapy outcomes expressed by maintenance of EASI 75 and IGA 0,1 response in atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.013
- By:
- Publication type:
- Article
Successful response to dupilumab in a refractory case of atopic dermatitis-like chronic cutaneous graft-versus-host disease.
- Published in:
- British Journal of Dermatology, 2024, v. 190, n. 4, p. 581, doi. 10.1093/bjd/ljad526
- By:
- Publication type:
- Article
Long-term 5-year safety of upadacitinib in moderate-to-severe atopic dermatitis: an integrated analysis including over 7000 patient-years of exposure.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii35, doi. 10.1093/bjd/ljad498.037
- By:
- Publication type:
- Article
Lebrikizumab demonstrates significant efficacy versus placebo across racial and ethnic subgroups in patients with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii20, doi. 10.1093/bjd/ljad498.024
- By:
- Publication type:
- Article
Efficacy and safety of lebrikizumab is maintained to two years in patients with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii3, doi. 10.1093/bjd/ljad498.005
- By:
- Publication type:
- Article
Dupilumab improves disease severity in children less than 12 years of age with moderate-severe AD: interim results from PEDISTAD real-world registry.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii13, doi. 10.1093/bjd/ljad498.017
- By:
- Publication type:
- Article
O02 Assessing SleeP in INfants with moderate-severe atopic Dermatitis by Longitudinal Evaluation (The SPINDLE study).
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. i1, doi. 10.1093/bjd/ljad483.002
- By:
- Publication type:
- Article
Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6–11 years with severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 2, p. 238, doi. 10.1093/bjd/ljad124
- By:
- Publication type:
- Article
427 Long-term 4-year safety of upadacitinib in moderate-to-severe atopic dermatitis: results of an integrated analysis of phase 3 studies.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.047
- By:
- Publication type:
- Article
426 Efficacy and safety of abrocitinib in adolescents with moderate-to-severe atopic dermatitis from the JADE clinical trial program.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.046
- By:
- Publication type:
- Article
413 Improvement in itch, symptoms and quality of life with upadacitinib through week 16 in adults and adolescents with atopic dermatitis: results from phase 3 studies (Measure Up 1, Measure Up 2 and AD Up).
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.033
- By:
- Publication type:
- Article
402 Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.025
- By:
- Publication type:
- Article
401 Safety and efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: an open-label study.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.024
- By:
- Publication type:
- Article
395 Assessing imputation methods with the lebrikizumab clinical trial program.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.020
- By:
- Publication type:
- Article
383 Integrated safety analysis of abrocitinib in 635 adolescent patients with moderate-to-severe atopic dermatitis with over 1000 patient-years of exposure.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.011
- By:
- Publication type:
- Article
340 Dupilumab treatment of children with moderateto-severe atopic dermatitis increases bone alkaline phosphatase, a marker of bone mineralization.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. ii28, doi. 10.1093/bjd/ljac140.034
- By:
- Publication type:
- Article
Risk factors for distant metastasis in cutaneous squamous cell carcinoma.
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 3, p. 435, doi. 10.1111/bjd.21250
- By:
- Publication type:
- Article
Children with atopic dermatitis show increased activity of β‐glucocerebrosidase and stratum corneum levels of glucosylcholesterol that are strongly related to the local cytokine milieu.
- Published in:
- British Journal of Dermatology, 2022, v. 186, n. 6, p. 988, doi. 10.1111/bjd.20979
- By:
- Publication type:
- Article
Population pharmacokinetic and exposure‐response modelling to inform upadacitinib dose selection in adolescent and adult patients with atopic dermatitis.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 10, p. 3139, doi. 10.1111/bcp.15803
- By:
- Publication type:
- Article
Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED) in the Irish Population.
- Published in:
- Journal of Pediatric Endocrinology & Metabolism, 2006, v. 19, n. 11, p. 1343, doi. 10.1515/jpem.2006.19.11.1343
- By:
- Publication type:
- Article